Document:

Exhibit
4.62

 

EMPLOYMENT AGREEMENT

BETWEEN

CHINA SUNERGY
CO., LTD. 

AND

 

Mr.
Shiliang Guo

 

Dated:
November 1, 2014

 

    	 

    	 

    

  

OFFSHORE EMPLOYMENT AGREEMENT

 

THIS
EMPLOYMENT AGREEMENT (this “Agreement”), dated November 1 2014, is entered into by and between CHINA SUNERGY
CO., LTD., a company organized and existing under the laws of the Cayman Islands (the “Company”), and Mr.
Shiliang Guo (“Acting Chief Financial Officer”), and shall become effective as of the date hereof (the “Effective
Date”).

 

WHEREAS,
the Company desires to employ Acting Chief Financial Officer and to enter into an agreement embodying the terms of such employment
on and after the Effective Date and considers it essential to its best interests and the best interests of its shareholders to
foster the employment of Acting Chief Financial Officer by the Company during the term of this Agreement; and

 

WHEREAS,
Acting Chief Financial Officer desires and is willing to enter into such employment with the Company and to enter into this Agreement;
and

 

NOW,
THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties
hereby agree as follows:

 

1.  Definitions.
For the purposes of this Agreement:

 

“Group”
means the Company and any company which is for the time being and from time to time, the
holding company, parent, subsidiary or Affiliate of the Company.

 

“Affiliate”
of a Person (the “Subject Person”) means any other Person directly or
indirectly controlling, controlled by or under common control with the Subject Person, where “control” means
the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise, and includes (a) ownership directly or indirectly
of 50% or more of the shares in issue or other equity interests of such Person, (b) possession directly or indirectly of 50% or
more of the voting power of such Person or (c) the power directly or indirectly to appoint a majority of the members of the board
of directors or similar governing body of such Person, and the terms “controlling” and “controlled”
have meanings correlative to the foregoing.

 

“Person”,
for the purpose of this Agreement, means an individual, corporation, joint venture, enterprise,
partnership, trust, unincorporated association, limited liability company, government or any department or agency thereof, or
any other entity.

 

2.  Term
of Employment. Subject to the provisions of Section 8 of this Agreement, this Agreement
shall be effective for a period commencing on the Effective Date and ending on the day when the Company enters into an employment
agreement with a Chief Financial Officer.

 

    	 

    	 

    

  

3.  Position.

 

 
(a) Acting Chief Financial Officer shall serve as the Chief Financial Officer of the Company. In
such position, Acting Chief Financial Officer shall have such duties and authority as shall be determined from time to time by
the Board of Directors of the Company (the “Board”). Acting Chief Financial Officer shall report to the Board.

 

(b)
During the Employment Term, Acting Chief Financial Officer will devote his business time and best efforts to the performance of
his duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise which would
conflict with the rendition of such services either directly or indirectly, without the prior written consent of the Board.

 

4.  Base
Salary. During the Employment Term, the Company shall pay Acting Chief Financial
Officer a salary (the “Base Salary”) at the annual rate of  $104,803, payable in regular installments
in accordance with the Company’s usual payroll practices. The Board may from time to time review and increase the Base
Salary in its sole discretion. During the Employment Term, the Acting Chief Financial Officer shall be eligible for any bonus
program approved by the Board for the benefit of the senior Acting Chief Financial Officers of the Company; provided
however, that the foregoing shall not create any presumption that a bonus will actually be granted by the Company to the
Acting Chief Financial Officer.

 

5.  Employee
Benefits. During the Employment Term, Acting Chief Financial Officer shall be provided with
benefits on the same basis as benefits are generally made available to other senior executives of the Company.

 

6.  Vacation. Acting
Chief Financial Officer shall be entitled to four (4) weeks annual paid vacation in accordance with the vacation accrual policy
of the Company.

 

7.  Business
Expenses. During the Employment Term, reasonable business expenses incurred by Acting Chief
Financial Officer in the performance of his duties hereunder shall be reimbursed by the Company in accordance with Company policies.

 

8.  Termination. Notwithstanding
any other provision of this Agreement:

 

(a)
For Cause by the Company. The Employment Term, and Acting Chief Financial Officer’s employment hereunder, may be
terminated at any time by the Company for “Cause” (as defined below) upon delivery of a “Notice of Termination”
(as defined in Section 8(e)) by the Company to Acting Chief Financial Officer. For purposes of this Agreement, “Cause”
shall mean, in each case, as reasonably determined by the Board: (i) conviction of, or entry of a pleading of guilty or no
contest by, Acting Chief Financial Officer with respect to a felony or any lesser crime of which fraud or dishonesty is a material
element; (ii) Acting Chief Financial Officer’s willful dishonesty towards the Company; (iii) Acting Chief Financial Officer’s
willful and continued failure to perform substantially all of his duties with the Company, or a failure to follow the lawful direction
of the Board after the Board delivers a written demand for substantial performance and Acting Chief Financial Officer neglects
to cure such a failure to the reasonable satisfaction of the Board within fifteen (15) days following receipt of such written
demand; (iv) Acting Chief Financial Officer’s material, knowing and intentional failure to comply with applicable laws with
respect to the execution of the Company’s business operations or his material breach of this Agreement; (v) Acting Chief
Financial Officer’s theft, fraud, embezzlement, dishonesty or similar conduct which has resulted or is likely to result
in material damage to the Company or any of its affiliates or subsidiaries; or (vi) Acting Chief Financial Officer’s habitual
intoxication or continued abuse of illegal drugs which materially interferes with Acting Chief
Financial Officer’s ability to perform his assigned duties and responsibilities.

 

    	 

    	 

    

  

If
Acting Chief Financial Officer is terminated for Cause pursuant to this Section 8(a), he shall be entitled to receive only his
Base Salary and authorized benefits through the date of termination and he shall have no further rights to any compensation (including
any Base Salary or Bonus) or any other benefits under this Agreement. All other benefits, if any, due to the Acting Chief Financial
Officer following Acting Chief Financial Officer’s termination of employment for Cause pursuant to this Section 8(a) shall
be determined in accordance with the plans, policies and practices of the Company; provided, however, that Acting Chief
Financial Officer shall not participate in any severance plan, policy or program of the Company.

 

(b) Disability
or Death. The Employment Term, and Acting Chief Financial Officer’s employment hereunder, shall terminate immediately
upon his death or following delivery of a Notice of Termination by the Company to Acting Chief Financial Officer if Acting Chief
Financial Officer becomes physically or mentally incapacitated and is therefore unable for a period of ninety (90) consecutive
days or one hundred twenty (120) days during any consecutive six (6) month period to perform his duties with substantially the
same level of quality as immediately prior to such incapacity (such incapacity is hereinafter referred to as “Disability”).
Upon termination of Acting Chief Financial Officer’s employment hereunder for either Disability or death, Acting Chief
Financial Officer or Acting Chief Financial Officer’s estate (as the case may be) shall be entitled to receive his Base
Salary through the date of termination and any earned but unpaid Bonus for any calendar year preceding the year in which the termination
occurs. Acting Chief Financial Officer or Acting Chief Financial Officer’s estate (as the case may be) shall have no further
rights to any compensation (including any Base Salary or Bonus) or any other benefits under this Agreement. All other benefits,
if any, due Acting Chief Financial Officer following Acting Chief Financial Officer’s termination for Disability or death
shall be determined in accordance with the plans, policies and practices of the Company; provided, however, that Acting Chief
Financial Officer (or his estate, as the case may be) shall not participate in any severance plan, policy or program of the Company.

 

    	 

    	 

    

  

(c) Without
Cause by the Company or for Good Reason by Acting Chief Financial Officer. The Employment Term, and Acting Chief Financial
Officer’s employment hereunder, may be terminated by the Company without Cause (other than by reason of Acting Chief Financial
Officer’s Disability) or by Acting Chief Financial Officer for “Good Reason” (as defined below) following the
delivery of a Notice of Termination to the other party. If Acting Chief Financial Officer’s employment is terminated by
the Company without Cause (other than by reason of Disability) or by Acting Chief Financial Officer for Good Reason, Acting Chief
Financial Officer shall receive, within thirty (30) days following termination, a lump sum payment of (i) any earned but unpaid
Base Salary through the date of termination and (ii) any earned but unpaid Bonus for any calendar year preceding the year in which
the termination occurs. In addition, subject to Acting Chief Financial Officer’s compliance with Sections 9, 10 and 11,
Acting Chief Financial Officer shall continue to receive in bi-weekly installments the Base Salary Acting Chief Financial Officer
would have otherwise received through the first (1st) anniversary of the date of termination in the case of termination
by the Company without Cause, or through the sixth (6th) month anniversary of the date of termination in the case of
termination by Acting Chief Financial Officer for Good Reason; provided, however, that if necessary to avoid additional
or accelerated taxation pursuant to Section 409A of the Code, Acting Chief Financial Officer will receive the first twelve (12)
installments of the foregoing payments on the six-month anniversary of the date of his termination in a lump sum payment and the
remainder of such payments, if any, shall thereafter be paid in bi-weekly installments through the first anniversary of the date
of termination. Acting Chief Financial Officer shall have no further rights to any compensation (including any Base Salary or
Bonus) or any other benefits under this Agreement. All other benefits, if any, due Acting Chief Financial Officer following a
termination pursuant to this Section 8(c) shall be determined in accordance with the plans, policies and practices of the Company;
provided, however, that Acting Chief Financial Officer shall not participate in any severance plan, policy or program of the Company.
If Acting Chief Financial Officer’s employment is terminated pursuant to this Section 8(c), the continued payment of Base
Salary shall be subject to Employee’s execution of a release in favor of the Company, its affiliates and their respective
officers, directors and employees in such form as may be required by the Company.

 

For purposes
of this Agreement, “Good Reason” means:

 

(i)  Any
failure by the Company to comply with any of the material provisions of this Agreement, other than an isolated, insubstantial
and inadvertent failure not occurring in bad faith;

 

(ii)  any
change in the duties or responsibilities (including reporting responsibilities) of Acting Chief Financial Officer that is inconsistent
in any material and adverse respect with Acting Chief Financial Officer’s position(s), duties or responsibilities with the
Company (including any material and adverse diminution of such duties or responsibilities); provided, however, that Good
Reason shall not be deemed to occur upon a change in duties or responsibilities (other than reporting responsibilities) that is
solely and directly a result of any event set forth in Section 8(a), (b) or (d); or

 

    	 

    	 

    

  

(iii)  any
failure by the Company to comply with the provisions of Section 4 of this Agreement;

 

provided that a
termination by Acting Chief Financial Officer with Good Reason shall be effective only if, within thirty (30) days following the
delivery of a Notice of Termination for Good Reason by Acting Chief Financial Officer to the Company, the Company has failed to
cure the circumstances giving rise to Good Reason.

 

(d)
Termination by Acting Chief Financial Officer without Good Reason. The Employment Term, and Acting Chief Financial Officer’s
employment hereunder, may be terminated by Acting Chief Financial Officer without Good Reason following the delivery of a Notice
of Termination to the Company. Upon a termination by Acting Chief Financial Officer pursuant to this Section 8(d), Acting Chief
Financial Officer shall be entitled to his Base Salary up to the date of such termination and he shall have no further rights
to any compensation (including any Base Salary or Bonus) or any other benefits under this Agreement. All other benefits, if any,
due Acting Chief Financial Officer following termination pursuant to this Section 8(d) shall be determined in accordance with
the plans, policies and practices of the Company; provided, however, that Acting Chief Financial Officer shall not participate
in any severance plan, policy or program of the Company.

 

(e)
Notice of Termination. Any purported termination of employment by the Company or Acting Chief Financial Officer (other
than on account of the death of Acting Chief Financial Officer) shall be communicated by a written Notice of Termination to Acting
Chief Financial Officer or the Company, respectively, delivered in accordance with Section 14(j) hereof. For purposes of this
Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision
in this Agreement relied upon, the date of termination, and shall set forth in reasonable detail the facts and circumstances claimed
to provide a basis for termination of employment under the provision so indicated. The date of termination of Acting Chief Financial
Officer’s employment shall be the date so stated in the Notice of Termination and shall be no less than thirty (30) days
following the delivery of a Notice of Termination; except that in the case of a termination by the Company for Cause in
accordance with the terms of Section 8(a) hereof, in which case the date of termination of Acting Chief Financial Officer’s
employment may be, at the sole discretion of the Company, the same date as the delivery of the Notice of Termination.

 

9.
Non-Competition/Non-Solicitation.

 

(a)
Acting Chief Financial Officer acknowledges and recognizes the highly competitive nature of the “Business” (as defined
below) of the Company and its subsidiaries and affiliates and accordingly agrees as follows:

 

    	 

    	 

    

  

(i)  (A)
The term “Business” means the manufacturing, whether directly by the Company or through its various subsidiaries
or Affiliates (including without limitation NJPV), of photovoltaic cells and such other related business activities as the Company
may engage in from time to time; (B) Acting Chief Financial Officer has intimate and valuable knowledge of the Business, as well
as technical, financial, customer, supplier and other confidential information related to the Business, which, if exploited by
Acting Chief Financial Officer in contravention of the terms of this Agreement, would seriously, adversely and irreparably affect
the ability of the Company to continue the Business; (C) the agreements and covenants contained in this Agreement, as they relate
to the Business and otherwise, have been determined by the Company to be essential to protect the Business and goodwill of the
Company; (D) for purposes of this Section 9, the Company shall be construed to include the Company and its subsidiaries and affiliates;
and (E) Acting Chief Financial Officer has the means to support himself and his dependents other than by engaging in the Business,
and the provisions of this Agreement will not impair such ability in any manner whatsoever.

 

(ii)  During
the Employment Term and until the third anniversary of the date Acting Chief Financial Officer ceases to be employed by the Company
(the “Restricted Period”), unless otherwise indicated in the disclosure letter, Acting Chief Financial Officer
will not directly or indirectly (A) engage in the Business for Acting Chief Financial Officer’s own account in China, (B)
enter the employ of, or render any services to, any Person engaged in the Business in the PRC, (C) acquire a financial interest
in, or otherwise become actively involved with, any person engaged in the Business in the PRC, directly or indirectly (and whether
or not for compensation), as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant,
or (D) interfere with business relationships (whether formed before or after the Effective Date) between the Company and customers
or suppliers of, or consultants to, the Company.

 

(iii)  During
the Employment Term, Acting Chief Financial Officer agrees not to appropriate, or fail to promptly notify and turn over to the
Company any corporate opportunity relating to or arising in connection with the Business of the Group, or engage in any activity
that is detrimental to the business of the Group or that limits the ability of the Group to fully exploit such corporate opportunities
or prevents the benefits of such corporate opportunities from accruing to the Group. For the avoidance of doubt, Acting Chief
Financial Officer may, by himself or through any entity controlled by him, engage in activities relating to solar power stations
business or, only when, after using best efforts, any entity within the Group fails to obtain the relevant governmental approvals,
in activities in connection with the Business of the Group.

 

(iv)  Notwithstanding
anything to the contrary in this Agreement, Acting Chief Financial Officer may, directly or indirectly, own, solely through passive
ownership as a portfolio investment (with no director designation rights or other special governance rights), securities of any
person engaged in the Business which are publicly traded on a national or regional stock exchange or on the over-the-counter market
if Acting Chief Financial Officer (A) is not a controlling person of, or a member of a group which controls, such person and (B)
does not, directly or indirectly, own 1% or more of any class of securities of such person.

 

    	 

    	 

    

 

(v)  During
the Restricted Period, Acting Chief Financial Officer will not, directly or indirectly, solicit or encourage to cease to work
with the Company, or directly or indirectly hire, any person who is an employee of or consultant then under contract with the
Company or who was an employee of or consultant then under contract with the Company within the one year preceding such activity
without the Company’s written consent.

 

(b)
It is expressly understood and agreed that although Acting Chief Financial Officer and the Company consider the restrictions contained
in this Section 9 to be reasonable, if a judicial determination is made by a court of competent jurisdiction that the time or
territory or any other restriction contained in this Agreement is an unenforceable restriction against Acting Chief Financial
Officer, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time
and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively,
if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction
cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions
contained herein.

 

10.
Nondisparagement. Acting Chief Financial Officer agrees (whether during or after Acting Chief Financial Officer’s employment
with the Company) not to issue, circulate, publish or utter any false or disparaging statements,
remarks or rumors about the Company or its affiliates or the officers, directors, managers or shareholders of the Company or its
affiliates unless giving truthful testimony under subpoena.

 

11.  Confidentiality.
Acting Chief Financial Officer shall not, without the prior written consent of the Company,
use, divulge, disclose or make accessible to any other person, firm, partnership, corporation or other entity, any “Confidential
Information” (as defined below) except while employed by the Company, in furtherance of the business of and for the benefit
of the Company or its affiliates; provided that Acting Chief Financial Officer may disclose such information when required to
do so by a court of competent jurisdiction, by any governmental agency having supervisory authority over the business of the Company
and/or its affiliates, as the case may be, or by any administrative body or legislative body (including a committee thereof) with
jurisdiction to order Acting Chief Financial Officer to divulge, disclose or make accessible such information; provided, further,
that in the event that Acting Chief Financial Officer is ordered by a court or other government agency to disclose any Confidential
Information or Personal Information, Acting Chief Financial Officer shall (i) promptly notify the Company of such order, (ii)
at the written request of the Company, diligently contest such order at the sole expense of the Company as expenses occur, and
(iii) at the written request of the Company, seek to obtain, at the sole expense of the Company, such confidential treatment as
may be available under applicable laws for any information disclosed under such order. For purposes of this Section 11, “Confidential
Information” shall mean non-public information concerning the financial data, strategic business plans, product development
(or other proprietary product data), customer lists, marketing plans and other non-public, proprietary and confidential information
relating to the business of the Company or its subsidiaries, affiliates or customers, that, in any case, is not otherwise available
to the public (other than by Acting Chief Financial Officer’s breach of the terms hereof). Upon termination of Acting Chief
Financial Officer’s employment with the Company and its affiliates, Acting Chief Financial Officer shall return all Company
property, including, without limitation, files, records, disks and any media containing Confidential Information, including all
copies thereto.

 

    	 

    	 

    

  

12.  Assignment
of Inventions.

 

(a)
Exhibit A hereto lists all inventions, original works of authorship, developments, improvements,
and trade secrets which were made by the Acting Chief Financial Officer prior to his employment with the Company (collectively
referred to as “Prior Inventions”), which belong to the Acting Chief Financial Officer, which relate to the
Company’s Business, products or research and development, and which are not assigned to the Company hereunder; or, if no
such list is attached, the Acting Chief Financial Officer represents that there are no such Prior Inventions.

 

(b)  If
in the course of his employment with the Company, the Acting Chief Financial Officer incorporates into a product, process or machine
of the Company and/or any other member of the Group a Prior Invention owned by him or in which he have an interest, the Company
and/or any member of the Group is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide
license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or
machine.

 

(c)  The
Acting Chief Financial Officer shall promptly make full written disclosure to the Company, will hold in trust for the sole right
and benefit of the Company, and hereby assign, free or charge, to the Company, or its designee, all the right, title, and interest
he may have in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries,
ideas, trademarks or trade secrets, processes, copyright works, know-how, Confidential Information, any other work’s information
or matter which gives rise or may give rise to any intellectual property of whatsoever nature, whether or not patentable or registrable
under any law of any country, which he may solely or jointly conceive or develop or reduce to practice, or cause to be conceived
or developed or reduced to practice, during his employment with the Company (collectively referred to as “Inventions”),
except as provided in Section 12(j) below.

 

    	 

    	 

    

  

(d)  The
Acting Chief Financial Officer acknowledges that the Company, or its designee, has the absolute title, right or interest in and
to any and all original inventions or works of authorship which are made by him, as an employee, (solely or jointly with others)
within the scope of and during the period of the employment with the Company and which inventions and works are the “service
invention-creation” and “works made for hire” as defined under applicable law. If any one or more of the aforementioned
Inventions can be protected by copyright and are not considered to be “service invention-creation” or “works
made for hire” as defined under applicable law, such items shall be deemed to be assigned and transferred completely and
exclusively to the Company, or its designee, by virtue of the execution of this Agreement by the Acting Chief Financial Officer.

 

(e)  The
Acting Chief Financial Officer acknowledges that the decision whether or not to commercialize or market any invention developed
by him solely or jointly with others is within the Company’ sole discretion and for the sole benefit of the Company and/or
any other member of the Group, and that no royalty will be due to the Acting Chief Financial Officer as a result of the Company’s
efforts (or the efforts of any member of the Group) to commercialize or market any such Invention.

 

(f)  The
Acting Chief Financial Officer shall keep and maintain adequate and current written records of all Inventions made by him (solely
or jointly with others) during the term of his employment with the Company. The records will be in the form of notes, sketches,
drawings, and any other format that may be specified by the Company. The records will be available to and remain the sole property
of the Company at all times.

 

(g)  The
Acting Chief Financial Officer shall assist the Company, or its designee, at the Company’s expense, in every proper way
to secure the Company’s (or its designee’s) rights in the Inventions and any copyrights, patents, mask work rights
or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all
pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and
all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign
and convey to its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions,
and any copyrights, patents, mask work rights or other intellectual property rights relating thereto, and to do all other things
reasonably requested by the Company, or its designee, (both during and after the term of this Agreement) in order to vest more
fully in the Company, or its designee, all ownership rights in the Inventions.

 

(h)  If
the Company is unable because of the Acting Chief Financial Officer’s mental or physical incapacity or for any other reason
to secure his signature to apply for or to pursue any application for any United States, PRC or foreign patents or copyright registrations
covering Inventions or original works of authorship assigned to the Company as set forth above, the Acting Chief Financial Officer
hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as his agent and attorney in
fact, to act for and in his behalf and stead to execute and file any such applications and to do all other lawfully permitted
acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and
effect as if executed by the Acting Chief Financial Officer.

 

    	 

    	 

    

  

(i)  With
respect to Inventions that are not considered as “service invention-creation” or “works made for hire”
under applicable law, to the extent that any application, registration or other governmental processes may be required in order
to protect the Company’s, or its designee’s ownership of any Inventions, the Acting Chief Financial Officer hereby
grants the Company, or its designee, an irrevocable power of attorney to execute all documents and do all acts in his name as
the Company, or its designee, may deem necessary or advisable to effect such processes and agrees to diligently and faithfully
assist the Company, or its designee, in effecting such processes.

 

(j)  Any
assignment of any Inventions under this Agreement includes all rights of paternity, integrity, disclosure and withdrawal and any
other rights that may be known as or referred to as “moral rights” (collectively “Moral Rights”).
To the extent such Moral Rights cannot be assigned under applicable law and to the extent the following is allowed by the laws
in the various countries where such Moral Rights exist, the Acting Chief Financial Officer hereby waives such Moral Rights and
consent to any action of the Company, or its designee, that would violate such Moral Rights in the absence of such consent. The
Acting Chief Financial Officer hereby covenants to confirm any such waivers and consents from time to time as requested by the
Company, or its designee.

 

(k)  In
respect of any inventions which are not Inventions but which relate to the business of the Company or Group, the Company or any
member of the Group shall have a pre-emptive right to acquire for itself or its nominee all or any part (at the Company’s
option) of the Acting Chief Financial Officer’s rights therein within three (3) months of their disclosure by the Acting
Chief Financial Officer to the Company under Section 12(c) above on such terms as shall be agreed by the Company and Acting Chief
Financial Officer. In the event that the Company or any member of the Group decides not to acquire such inventions, the Acting
Chief Financial Officer hereby grants to the Company, a perpetual, worldwide, irrevocable, royalty-free, fully paid-up, exclusive
license to use for any and all purposes and in any manner any such other inventions that are within the scope of the actual and
anticipated business of the Company or the Group.

 

13.  Enforcement
of Restrictive Covenants. Acting Chief Financial Officer acknowledges and agrees that the
Company’s remedies at law for a breach or threatened breach of any of the provisions of Sections 9, 10, 11 or 12 herein
would be inadequate and, in recognition of this fact, Acting Chief Financial Officer agrees that, in the event of such a breach
or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to obtain equitable
relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable
remedy which may then be available. In addition, upon a violation by Acting Chief Financial Officer of Section 9, 10, 11 or 12,
as determined in good faith by the Board, all payments remaining due to Acting Chief Financial Officer pursuant to Section
8(c), if applicable, shall immediately cease.

 

    	 

    	 

    

  

14.  Miscellaneous.

 

(a)
Acceptance. Acting Chief Financial Officer hereby
represents that his performance and execution of this Agreement does not and will not constitute a breach of any agreement or
arrangement to which he is a party or is otherwise bound, including, without limitation, any noncompetition or employment agreement.

 

(b)
GOVERNING LAW; CONSENT TO JURISDICTION. THIS AGREEMENT
SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK OF THE UNITED STATES OF AMERICA APPLICABLE
TO AGREEMENTS MADE AND TO BE WHOLLY PERFORMED WITHIN THAT STATE, WITHOUT REGARD TO THE CONFLICT OF LAWS PROVISIONS OF ANY JURISDICTION
WHICH WOULD CAUSE THE APPLICATION OF ANY LAW OTHER THAN THAT OF THE STATE OF NEW YORK. ANY ACTION TO ENFORCE THIS AGREEMENT AND/OR
THE EXHIBITS HERETO (OTHER THAN AN ACTION WHICH MUST BE BROUGHT BY ARBITRATION PURSUANT TO SECTION 14(d)) MUST BE BROUGHT IN,
AND THE PARTIES HEREBY CONSENT TO THE JURISDICTION OF, A COURT SITUATED IN NEW YORK COUNTY, NEW YORK. EACH PARTY HEREBY WAIVES
THE RIGHTS TO CLAIM THAT ANY SUCH COURT IS AN INCONVENIENT FORUM FOR THE RESOLUTION OF ANY SUCH ACTION.

 

(c)
JURY TRIAL WAIVER. THE PARTIES EXPRESSLY AND KNOWINGLY
WAIVE ANY RIGHT TO A JURY TRIAL IN THE EVENT ANY ACTION ARISING UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ACTING CHIEF FINANCIAL
OFFICER’S EMPLOYMENT WITH THE COMPANY IS LITIGATED OR HEARD IN ANY COURT.

 

(d)
Arbitration; Legal Fees. Except to the extent contemplated by Section 13, any dispute, controversy or other claim arising
out of or relating to (i) this Agreement, or (ii) Acting Chief Financial Officer’s employment with the Company shall be
resolved by binding confidential arbitration before a single arbitrator, to be held in New York, New York in accordance with the
Commercial Arbitration Rules of the American Arbitration Association. Judgment upon the award rendered by the arbitrator may be
entered in any court having jurisdiction thereof. Each party shall be responsible for its own expenses relating to the conduct
of the arbitration or litigation (including reasonable attorneys’ fees and expenses) and shall share the fees of the American
Arbitration Association and the arbitrator, if applicable, equally.

 

(e)
Entire Agreement/Effectiveness of this Agreement.
This Agreement constitutes the entire agreement between the parties as of the Effective Date and supersedes all previous agreements
and understandings between the parties with respect to the subject matter thereof. Acting Chief Financial Officer hereby acknowledges
and agrees that the Prior Employment Agreement shall terminate as of immediately prior to the Effective Date and Acting Chief
Financial Officer shall have no further rights thereunder and the Company and its affiliates shall have no further obligations
thereunder.

 

    	 

    	 

    

  

(f)  Amendments.
There are no restrictions, agreements, promises, warranties, covenants or undertakings between
the parties with respect to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered,
modified, or amended except by written instrument signed by the parties hereto. Sections 9, 10, 11, 12 and 13 survive the termination
of this Agreement and the termination of Acting Chief Financial Officer’s employment with the Company, except as otherwise
specifically stated therein.

 

(g)  No
Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement
on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to
insist upon strict adherence to that term or any other term of this Agreement.

 

(h)  Severability.
In the event that any one or more of the provisions of this Agreement shall be or become
invalid, illegal or unenforceable in any respect, each such provision shall be processed with whatever deletion or modification
is necessary so that the provision is otherwise legal, valid and enforceable and gives effect to the commercial intention of the
parties. To the extent it is not possible to delete or modify the provision, in whole or in part, then such provision or part
of it shall, to the extent that it is illegal, invalid or unenforceable, be deemed not to form part of this Agreement and the
validity, legality and enforceability of the remaining provisions of this Agreement shall, subject to any deletion or modification
made hereunder, not be affected.

 

(i)  Assignment.
Acting Chief Financial Officer shall not have the right to assign his interest in this Agreement,
any rights under this Agreement or any duties imposed under this Agreement. This Agreement may be assigned by the Company to any
successor in interest to substantially all of the business operations of the Company. Such assignment shall become effective when
the Company notifies Acting Chief Financial Officer of such assignment or at such later date as may be specified in such notice.
Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such successor
company.

 

(j)  Notice.
For the purpose of this Agreement, notices and all other communications provided for in
this Agreement shall be in writing and shall be deemed to have been duly given if delivered personally, if delivered by overnight
courier service, if sent by facsimile transmission or if mailed by registered mail, return receipt requested, postage prepaid,
addressed to the respective addresses or sent via facsimile to the respective facsimile numbers, as the case may be, as set forth
below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that
notice of change of address shall be effective only upon receipt; provided, however, that (i) notices sent by personal delivery
or overnight courier shall be deemed given when delivered; (ii) notices sent by facsimile transmission shall be deemed given upon
the sender’s receipt of confirmation of complete transmission, and (iii) notices sent by United States registered mail shall
be deemed given seven (7) days after the date of deposit in the United States mail.

 

    	 

    	 

    

  

If to
Acting Chief Financial Officer, to:

123
Focheng West Road

Jiangning
Economic & Technical Development Zone

Nanjing,
PRC 211100

Facsimile:
+86 (25) 5276-6579

Attention:
Shiliang Guo

If to
the Company, to:

123
Focheng West Road

Jiangning
Economic & Technical Development Zone

Nanjing,
PRC 211100

Facsimile:
+86 (25) 5276-6579

Attention:
Shiliang Guo

 

(k)  Withholding
Taxes. The Company may withhold from any amounts payable under this Agreement such Federal, state, local and foreign taxes
as may be required to be withheld pursuant to any applicable law or regulation.

 

(l)  Continuation
of Employment. Unless the parties otherwise agree in writing, continuation of Acting Chief
Financial Officer ’s employment with the Company beyond the expiration of the Employment Term shall be deemed an employment
“at will” and shall not be deemed to extend any of the provisions of this Agreement, and Acting Chief Financial Officer’s
employment may thereafter be terminated at will by Acting Chief Financial Officer or the Company.

 

(m)  Counterparts.
This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument.

 

[THE REMAINDER OF
THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

    	 

    	 

    

  

IN
WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.

 

	 	ACTING CHIEF FINANCIAL OFFICER
	 	 
	 	/s/ Shiliang Guo
	 	 
	 	CHINA SUNERGY CO., LTD
	 	 
	 	By: 	/s/ Tingxiu Lu
	 	Name: Tingxiu Lu
	 	Title: Authorized Representative 

 

    	 

    	 

    

 

EXHIBIT A

 

Prior InventionsExhibit 4.63

 

CHINA
SUNERGY CO., LTD.

 

DIRECTOR AGREEMENT

 

This Director
Agreement (the “Agreement”) is made and entered into as of Dec. 30th, 2014, by and between China
Sunergy Co., Ltd., a Cayman Islands company ( the “Company”), and Cheng Hong, an individual (the “Independent
Director”).

 

I.            SERVICES

 

1.1 Board
of Directors. Director has been appointed as an Independent Director of the Company’s Board of Directors (the “Board”).
The Board shall consist of the Director and such other members as nominated and elected pursuant to the then current Memorandum
and Articles of Association of the Company (the “Articles”).

 

1.2 Director
Services. Director’s services to the Company hereunder shall include service on the Board to manage the business of
the Company in accordance with applicable law and the then current Articles, and such other services mutually agreed to by Director
and the Company (the “Director Services”).

 

II.          COMPENSATION

 

2.1 Fees to
Director. The Company agrees to pay Director the following fees for the Director Services: an annual retainer of approximately
US$30,000 before tax paid monthly at the end of each calendar month. In the event Director ceases to serve on the Board for any
reason, Director shall be entitled to the pro rata portion of the annual fee for the number of months he has served on the Board
in a given year.

 

2.2 Expenses.
The Company shall reimburse the Director for any travel entertainment and other out-of-pocket expenses reasonably incurred
by him in the performance of his duties, subject to the approval procedures of the Company.

 

2.2
Share Option. To the extent the Company adopts and maintains a share incentive plan and subject to approval by the Board,
the Director will be eligible to participate in such plan pursuant to the terms thereof as determined by the Company.

 

2.3 Director
and Officer Liability Insurance. The Company’s director and officer liability insurance policy shall provide Director
with coverage for damages and losses incurred in connection with the Director Services.

 

III.         duties
of director

 

3.1 Fiduciary
Duties. In fulfilling his managerial responsibilities, Director shall be charged with a fiduciary duty to the Company and
all of its shareholders. Director shall be attentive and inform himself of all material facts regarding a decision before taking
action. In addition, Director’s actions shall be motivated solely by the best interests of the Company and its shareholders.

 

    	 

    	 

    

  

3.2 Confidentiality.
During the term of this Agreement, and for a period of two(2) years after the Expiration Date, Director shall maintain in strict
confidence all information he has obtained or shall obtain from the Company which the Company has designated as “confidential”
or which is, by its nature confidential, relating to the Company’s business, operations, properties, assets, services, condition
(financial or otherwise), liabilities, employee relations, customers (including customer usage statistics), suppliers, prospects,
technology, or trade secrets, except to the extent such information (i) is in the public domain through no act or omission
of the Company, (ii) is required to be disclosed by law or a valid order by a court or other governmental body, or (iii) is
independently learned by Director outside of this relationship (the “Confidential Information”).

 

3.3 Nondisclosure
and Nonuse Obligations. Director will use the Confidential Information solely to perform the Director Services for the benefit
of the Company. Director will treat all Confidential Information of the Company with the same degree of care as Director treats
his own Confidential Information, and Director will use its best efforts to protect the Confidential Information. Director will
not use the Confidential Information for his own benefit or the benefit of any other person or entity, except as may be specifically
permitted in this Agreement. Director will immediately give notice to the Company of any unauthorized use or disclosure by or
through him, or of which he becomes aware, of the Confidential Information. Director agrees to assist the Company in remedying
any such unauthorized use or disclosure of the Confidential Information.

 

3.4 Return
of the Company Property. All materials furnished to Director by the Company, whether delivered to Director by the Company
or made by Director in the performance of Director Services under this Agreement (the “Company Property”)
are the sole and exclusive property of the Company. Director agrees to promptly deliver the original and any copies of the Company
Property to the Company at any time upon the Company’s request. Upon termination of this Agreement by either party for any
reason, Director agrees to promptly deliver to the Company or destroy, at the Company’s option, the original and any copies
of the Company Property. Director agrees to certify in writing that Director has so returned or destroyed all such the Company
Property.

 

IV.         COVENANTS
OF director

 

4.1 No
Conflict of Interest. During the term of this Agreement, and for a period of two(2) years after the Expiration Date, Director
shall not be employed by, own, manage, control or participate in the ownership, management, operation or control of any business
entity that is competitive with the Company or otherwise undertake any obligation inconsistent with the terms hereof, provided
that Director may continue Director’s current affiliation or other current relationships with the entity or entities described
on Exhibit A (all of which entities are referred to collectively as “Current
Affiliations”). This Agreement is subject to the current terms and agreements governing Director’s relationship
with Current Affiliations, and nothing in this Agreement is intended to be or will be construed to inhibit or limit any of Director’s
obligations to Current Affiliations. Director represents that nothing in this Agreement conflicts with Director’s obligations
to Current Affiliations. A business entity shall be deemed to be “competitive with the Company” for purpose of this
Article IV only if and to the extent it engages in the business substantially similar to the Company’s business.

 

    	2

    	 

    

  

4.2 Noninterference
with Business. During the term of this Agreement, and for a period of two(2) years after the Expiration Date, Director agrees
not to interfere with the business of the Company in any manner. By way of example and not of limitation, Director agrees not
to solicit or induce any employee, independent contractor, customer or supplier of the Company to terminate or breach his or her
employment, contractual or other relationship with the Company.

 

V.          Term
and Termination

 

5.1 Term.
This Agreement is effective as of the date first written above and will continue until the date on which Director ceases to be
a member of the Board for any reason (the “Expiration Date”), or until terminated in accordance with this Section
5.2.

 

5.2 Termination.
Either party may terminate this Agreement at any time upon thirty (30) days prior written notice to the other party, or such shorter
period as the parties may agree upon.

 

5.3 Survival.
The rights and obligations contained in Articles III and IV will survive any termination or expiration of this Agreement.

 

VI.         Miscellaneous

 

6.1 Assignment.
Except as expressly permitted by this Agreement, neither party shall assign, delegate, or otherwise transfer any of its rights
or obligations under this Agreement without the prior written consent of the other party. Subject to the foregoing, this Agreement
will be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors
and assigns.

 

6.2 No
Waiver. The failure of any party to insist upon the strict observance and performance of the terms of this Agreement shall
not be deemed a waiver of other obligations hereunder, nor shall it be considered a future or continuing waiver of the same terms.

 

6.3 Notices.
Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice deemed given
as indicated: (i) by personal delivery when delivered personally; (ii) by overnight courier upon written verification
of receipt; (iii) by facsimile transmission upon acknowledgment of receipt of electronic transmission; or (iv) by certified
or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to the addresses set forth above
or such other address as either party may specify in writing.

 

6.4 Governing
Law. This Agreement shall be governed in all respects by the laws of the United States of America and by the laws of the State
of New York, without regard to conflicts of law principles thereof.

 

6.5 Severability.
Should any provisions of this Agreement be held by a court of law to be illegal, invalid or unenforceable, the legality, validity
and enforceability of the remaining provisions of this Agreement shall not be affected or impaired thereby.

 

    	3

    	 

    

  

6.6 Entire
Agreement. This Agreement constitutes the entire agreement between the parties relating to this subject matter and supersedes
all prior or contemporaneous oral or written agreements concerning such subject matter. The terms of this Agreement will govern
all Director Services undertaken by Director for the Company.

 

6.7 Amendments.
This Agreement may only be amended, modified or changed by an agreement signed by the Company and Director. The terms contained
herein may not be altered, supplemented or interpreted by any course of dealing or practices.

 

6.8 Counterparts.
This Agreement may be executed in two counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

 

    	4

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first written above.

 

	Company:	China Sunergy Co., Ltd.
		 
	 	By:	/s/ Tingxiu
    Lu
	 	Name:	  Tingxiu Lu
	 	Title:	  Chairman and Chief Executive
    Officer
	 	 
	Independent Director:	 
	 	 
	 	/s/ Cheng Hong
	 	Name:  Cheng Hong

  

    	5

    	 

    

 

EXHIBIT
A

 

Director’s
Current Affiliations

 

    	A - 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]